{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:53:13Z","timestamp":1792666393328,"version":"4.5.0"},"reference-count":23,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"unspecified","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,8,14]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Maternal respiratory syncytial virus (RSV) vaccination has been introduced to protect infants from severe respiratory infections. However, its uptake and impact on perinatal outcomes are unknown in the UK.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To evaluate uptake of RSV vaccine during pregnancy in a UK population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>This cross-sectional study was conducted at a tertiary maternity hospital in London. The participants included pregnant women who delivered between 1 September and 17 December 2024 (n=1157). For the analysis of vaccine uptake, the cohort included women eligible for vaccination who delivered beyond 28 weeks\u2019 gestation and were at 36 weeks or less on 1 September 2024 (n=911). The main outcome measures were RSV vaccine uptake and its association with sociodemographic factors, perinatal outcomes including preterm birth (PTB), hypertensive disorders of pregnancy and stillbirth.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 911 eligible women, 19% (n=173) received the RSV vaccine during pregnancy. Uptake increased significantly from 4% in September to 32% in December (p&lt;0.001). Vaccinated women were older (median age 35 vs 32 years, p&lt;0.001), more likely to be white (66.3% vs 46.5%, p&lt;0.001), and from higher socioeconomic quintiles (Index of Multiple Deprivation quintile 5: 18.5% vs 11.2%, p=0.029). Smoking during pregnancy was less common in vaccinated women (0.6% vs 5.0%, p=0.016). Multivariable logistic regression identified older maternal age (p=0.001), higher socioeconomic status (IMD quintile 1 vs 5; adjusted OR (aOR) 0.28, 95%\u2009CI 0.08 to 0.81, p=0.030) and ethnicity (Asian: aOR 0.56, 95%\u2009CI 0.35 to 0.88, p=0.015, black: aOR 0.52, 95%\u2009CI 0.28 to 0.95, p=0.040, mixed: aOR 0.12, 95% CI 0.02 to 0.39, p=0.004) as independent predictors of vaccine uptake. PTB rates at &lt;37 weeks were comparable between groups (9.6% vs 10.0%, p=0.980), but no vaccinated women experienced PTB&lt;34 weeks compared with 3.2% of unvaccinated women (p=0.032). Caesarean section rates were higher among vaccinated women (52.0% vs 35.5%, p&lt;0.001). No significant differences were observed in other perinatal outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>RSV vaccine uptake shows significant increases over time, with disparities in uptake by ethnicity and socioeconomic status. Further research is needed to increase vaccination rates, particularly in disadvantaged groups, and evaluate perinatal outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-101592","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T07:25:19Z","timestamp":1758785119000},"page":"e101592","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Perinatal outcomes and uptake of RSV vaccine during pregnancy in South London: a cross-sectional study"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6671-5557","authenticated-orcid":false,"given":"Mohammad Sharif","family":"Razai","sequence":"first","affiliation":[{"name":"Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Kalafat","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Ko\u00e7 \u00dcniversitesi, Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2329-4470","authenticated-orcid":false,"given":"Smriti","family":"Prasad","sequence":"additional","affiliation":[{"name":"Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, City St George\u2019s, University of London, London, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelone","family":"Lee-Wo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, St George\u2019s NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7540-7433","authenticated-orcid":false,"given":"Paul T","family":"Heath","sequence":"additional","affiliation":[{"name":"Vaccine Institute, Institute of Infection and Immunity, City St Georges, University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2802-7670","authenticated-orcid":false,"given":"Asma","family":"Khalil","sequence":"additional","affiliation":[{"name":"Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, City St George\u2019s, University of London, London, England, UK"},{"name":"Royal College of Obstetricians and Gynaecologists, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"2025092500250872000_15.9.e101592.1","unstructured":"UK Government . Independent report. Respiratory syncytial virus (RSV) immunisation programme for infants and older adults: JCVI full statement. 2023 Available: https:\/\/bit.ly\/3X5yWmt"},{"key":"2025092500250872000_15.9.e101592.2","unstructured":"European Vaccination Information Portal . RSV factsheet. n.d. Available: https:\/\/vaccination-info.europa.eu\/en\/rsv"},{"key":"2025092500250872000_15.9.e101592.3","unstructured":"UK Government . A guide to RSV vaccination for pregnant women. 2024. Available: https:\/\/bit.ly\/4jYPKp0"},{"key":"2025092500250872000_15.9.e101592.4","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2023.100829","article-title":"Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination","volume":"38","author":"Hodgson","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"2025092500250872000_15.9.e101592.5","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2216480"},{"key":"2025092500250872000_15.9.e101592.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2305478"},{"key":"2025092500250872000_15.9.e101592.7","unstructured":"Haute Autorite De Sante . Recommandation vaccinale contre les infections \u00e0 VRS chez les femmes enceintes. n.d. Available: https:\/\/www.has-sante.fr\/jcms\/p_3505344\/fr\/recommandation-vaccinale-contre-les-infections-a-vrs-chez-les-femmes-enceintes"},{"key":"2025092500250872000_15.9.e101592.8","unstructured":"UKHSA . RSV vaccination of pregnant women for infant protection: information for healthcare practitioners. 2025. Available: https:\/\/www.gov.uk\/government\/publications\/respiratory-syncytial-virus-rsv-programme-information-for-healthcare-professionals\/rsv-vaccination-of-pregnant-women-for-infant-protection-information-for-healthcare-practitioners"},{"key":"2025092500250872000_15.9.e101592.9","unstructured":"UK Government Guidance . Respiratory syncytial virus: the green book, chapter 27a. 2024. Available: https:\/\/www.gov.uk\/government\/publications\/respiratory-syncytial-virus-the-green-book-chapter-27a"},{"key":"2025092500250872000_15.9.e101592.10","unstructured":"UKHSA . RSV maternal vaccination coverage in England. 2024 Available: https:\/\/www.gov.uk\/government\/publications\/rsv-immunisation-for-older-adults-and-pregnant-women-vaccine-coverage-in-england\/rsv-maternal-vaccination-coverage-in-england-september-2024"},{"key":"2025092500250872000_15.9.e101592.11","unstructured":"UKHSA . RSV maternal vaccination coverage in England. 2025. Available: https:\/\/www.gov.uk\/government\/publications\/rsv-immunisation-for-older-adults-and-pregnant-women-vaccine-coverage-in-england\/rsv-maternal-vaccination-coverage-in-england-january-2025"},{"key":"2025092500250872000_15.9.e101592.12","unstructured":"UK Government . Respiratory syncytial virus (RSV): symptoms, transmission, prevention, treatment. n.d. Available: https:\/\/www.gov.uk\/government\/publications\/respiratory-syncytial-virus-rsv-symptoms-transmission-prevention-treatment\/respiratory-syncytial-virus-rsv-symptoms-transmission-prevention-treatment"},{"key":"2025092500250872000_15.9.e101592.13","unstructured":"NHS England . 20-week screening scan. GOV.UK; 2022. Available: https:\/\/www.gov.uk\/government\/publications\/fetal-anomaly-screening-programme-handbook\/20-week-screening-scan [Accessed 11 Jul 2025]."},{"key":"2025092500250872000_15.9.e101592.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2021.09.008"},{"key":"2025092500250872000_15.9.e101592.15","unstructured":"National Institute for Health and Care Excellence . Intrapartum care. 2023. Available: https:\/\/www.nice.org.uk\/guidance\/ng235\/chapter\/Recommendations [Accessed 11 Jul 2025]."},{"key":"2025092500250872000_15.9.e101592.16","first-page":"e106","article-title":"Prevention and management of postpartum haemorrhage","volume":"124","author":"Mavrides","year":"2016","journal-title":"BJOG"},{"key":"2025092500250872000_15.9.e101592.17","unstructured":"Royal College of Obstetricians and Gynaecologists . Antepartum haemorrhage (green-top guideline no.63). 2011. Available: https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/antepartum-haemorrhage-green-top-guideline-no-63\/ [Accessed 11 Jul 2025]."},{"key":"2025092500250872000_15.9.e101592.18","unstructured":"NHS England . NHS public health functions agreement 2019-20. 2020. Available: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2017\/04\/Service-Specification-No.17-FASP-Fetal-Anomaly-Scan.pdf [Accessed 11 Jul 2025]."},{"key":"2025092500250872000_15.9.e101592.19","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taad138","article-title":"Interventions to increase vaccination against COVID-19, influenza and pertussis during pregnancy: a systematic review and meta-analysis","volume":"30","author":"Razai","year":"2023","journal-title":"J Travel Med"},{"key":"2025092500250872000_15.9.e101592.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298407","article-title":"Facilitators and Barriers to Vaccination Uptake in Pregnancy: A Qualitative Systematic Review","volume":"19","author":"Razai","year":"2023","journal-title":"PLoS ONE"},{"key":"2025092500250872000_15.9.e101592.21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.19268","article-title":"Nonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes","volume":"7","author":"Son","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2025092500250872000_15.9.e101592.22","unstructured":"NHS England . RSV vaccinations, 2025. Available: https:\/\/www.england.nhs.uk\/statistics\/statistical-work-areas\/vaccinations-rsv"},{"key":"2025092500250872000_15.9.e101592.23","unstructured":"UKHSA . RSV maternal vaccination coverage in England. 2024. Available: https:\/\/www.gov.uk\/government\/publications\/rsv-immunisation-for-older-adults-and-pregnant-women-vaccine-coverage-in-england\/rsv-maternal-vaccination-coverage-in-england-december-2024"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-101592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T07:25:25Z","timestamp":1758785125000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-101592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,24]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjopen-2025-101592"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-101592","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}